What Is a Liquid Biopsy — and Why It Matters for People Living With Breast Cancer

For many people facing breast cancer, laboratory testing plays a critical role in guiding treatment decisions. Traditionally, testing has relied on tissue biopsies, where a small sample of the tumor is removed during a procedure. While tissue biopsies remain very important, a newer approach called a liquid biopsy is helping doctors learn more about cancer in a simpler, less invasive way.

Liquid biopsy is becoming an exciting tool in the evolving field of precision oncology.

What Is a Liquid Biopsy?

A liquid biopsy is a blood test that looks for tiny fragments of cancer-related material circulating in the bloodstream. Tumors naturally shed small pieces of DNA into the blood, called circulating tumor DNA (ctDNA). By analyzing a simple blood sample, doctors may be able to detect these fragments and learn more about the cancer.

Unlike a traditional biopsy, a liquid biopsy does not require surgery or a needle placed directly into a tumor.

Instead, it works much like a routine blood draw.

Why Is This Important for Breast Cancer?

Breast cancer is not a single disease. Every tumor can have different genetic features that affect how it behaves and which treatments may work best. Liquid biopsy can help doctors better understand these features and monitor how the cancer changes over time.

This information can support more personalized treatment decisions.

Some ways liquid biopsy may help include:

Finding Treatment Targets

Liquid biopsy can sometimes identify genomic changes in cancer cells that may respond to targeted therapies. For example, certain mutations can help doctors determine whether a patient might benefit from specific precision medicines.

Detecting Recurrent Cancer Earlier After Treatment

In some cases, a liquid biopsy may be able to detect very small amounts of cancer that remain in the body after surgery or treatment. This is often called molecular residual disease (MRD). Detecting MRD earlier may help doctors monitor patients more closely and make treatment adjustments if needed.

A Less Invasive Option

One of the most meaningful advantages of a liquid biopsy is that it requires only a blood sample.

Traditional tissue biopsies can sometimes be difficult or uncomfortable, particularly if the tumor is in a location that is hard to reach, while liquid biopsies may provide useful information without requiring additional procedures.

For patients already going through treatment, this can reduce stress and make ongoing monitoring easier.

Supporting the Future of Personalized Cancer Care

Liquid biopsy is part of a broader movement toward precision medicine—an approach where treatments are tailored to the unique biology of each patient’s cancer.

Researchers continue to study how these tests can be used to improve care for people with breast cancer. Clinical trials and ongoing studies help doctors understand when liquid biopsy provides the most benefit and how it can complement existing testing methods.

While it may not replace traditional biopsies in every situation, liquid biopsy is becoming an important additional tool in cancer care.

What Patients Should Know

If you or a loved one is living with breast cancer, you may want to ask your healthcare team about the types of testing available to guide treatment decisions.

Every patient’s situation is different, and your doctor can help determine whether certain tests—including liquid biopsy—may be appropriate for your care.

Moving Toward More Personalized Care

Advances in cancer testing are helping doctors better understand breast cancer and how it changes over time. Tools like liquid biopsy are opening the door to more personalized monitoring, more informed treatment choices, and potentially earlier insights into how cancer is responding.

For patients and advocates alike, these innovations represent another step forward in the effort to improve outcomes and quality of life for people affected by breast cancer.